Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3802829
rs3802829
TRPC6
0.010 GeneticVariation BEFREE The p.P15S polymorphism might have some influence on the therapeutic response of FSGS patients. 22980509

2012
dbSNP: rs74315344
rs74315344
NPHS2
0.010 GeneticVariation BEFREE The prevalence of p.P20L polymorphism was not significantly different among the groups (6 % in FSGS patients, 1.8 % in IGAN patients, 1 % in the control group). 22578956

2012
dbSNP: rs761613959
rs761613959
MUC1
0.010 GeneticVariation BEFREE The prevalence of p.P20L polymorphism was not significantly different among the groups (6 % in FSGS patients, 1.8 % in IGAN patients, 1 % in the control group). 22578956

2012
dbSNP: rs779430565
rs779430565
TRPC6
0.010 GeneticVariation BEFREE The first new mutation, p.H218L, was found in a 18-year-old boy who presented a severe form of FSGS at the age of 8 years. 21734084

2011
dbSNP: rs1003629254
rs1003629254
EIF2AK3
0.010 GeneticVariation BEFREE A compound heterozygous podocin mutation was identified in our FSGS patient, leading to a truncated (podocin (V165X)) and a missense mutant protein (podocin (R168H)), respectively. 19674119

2009
dbSNP: rs530318579
rs530318579
NPHS2
0.010 GeneticVariation BEFREE A compound heterozygous podocin mutation was identified in our FSGS patient, leading to a truncated (podocin (V165X)) and a missense mutant protein (podocin (R168H)), respectively. 19674119

2009